109-01-3 + 1449314-09-3 = 898280-07-4 反应条件:1.1 Solvents: Dimethylacetamide; 15 Min,88 °C; 255 Min,90 °C 标题:Process Development And Multikilogram Syntheses Of Xl228 Utilizing A Regioselective Isoxazole Formation And A Selective Snar Reaction To A Pyrimidine Core 作者:Guz,Nathan R.; Leuser,Helena; Goldman,Erick 参考文献:Organic Process Research & Development 日期:2013 卷标:17(8) 页码:1066-1073
N-(4,6-Dichloropyrimidin-2-yl)-N-(Prop-2-Ynyl)Acetamide置于potassium Hydrogencarbonate体系中,用 N,N-二甲基乙酰胺,醋酸异丙酯 作为反应溶剂,化学反应 39.5H,反应生成 N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺 参考文献:Process Development And Multikilogram Syntheses Of Xl228 Utilizing A Regioselective Isoxazole Formation And A Selective Snar Reaction To A Pyrimidine Core 标题:Process Development And Multikilogram Syntheses Of Xl228 Utilizing A Regioselective Isoxazole Formation And A Selective Snar Reaction To A Pyrimidine Core 摘要:Route Scouting,Process Development,And Multikilogram Syntheses Of An Igf-1R/src/bcr-Abl Inihibitor Are Reported. Key Aspects Of The Developed Route Are A Regioselective [3 + 2] Isoxazole Formation On A Pyrimidine Core And A Selective Snar Addition Of An Aryl Amine To A Symmetrical Dichloro Substituted Pyrimidine. The Route Contains Six Synthetic Steps And Was Demonstrated Twice On Scale,Delivering 4.6 And 11.2 Kg (25% And 16% Overall Yield),For Phase I Clinical Studies. DOI:10.1021/op400137M
专利号:WO-2025128098-A1 优先权日:2023-12-13 标 题 :Solid oral dosage forms, kits, and methods of using the same 发明人:LI YING; LANGER ROBERT; TRAVERSO CARLO 权利人:MASSACHUSETTS INST TECHNOLOGY; BRIGHAM & WOMENS HOSPITAL INC 摘要:Provided herein are solid oral dosage forms, methods, and kits useful, e.g, for the extension of the residence time of active pharmaceutical agents in vivo by the synthesis of a polymer in situ in a subject. In particular, the solid oral dosage forms, methods, and kits disclosed herein are particularly useful for drugs that require more than once daily administration (e.g, drugs that have short half-lives).
专利号:US-12180228-B2 优先权日:2019-06-05 标题:Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof 发明人:MOVASSAGHI MOHAMMAD; OLSSON CHASE ROBERT; SCOTT TONY Z; CHEAH JAIME; PAYETTE JOSHUA NATHANIEL 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:The present disclosure provides, e.g., compounds, compositions, kits, methods of synthesis, and methods of use, involving epipolythiodiketopiperazines and polythiodiketopiperazines.
1: Edilova MI, Law JC, Zangiabadi S, Ting K, Mbanwi AN, Arruda A, Uehling D, Isaac M, Prakesch M, Al-Awar R, Minden MD, Abdul-Sater AA, Watts TH. The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia. Oncoimmunology. 2021 Sep 23;10(1):1943234. doi: 10.1080/2162402X.2021.1943234. 2: Patel A, Li L, Anand A. Systematic review: functional outcomes and complications of intramedullary nailing versus plate fixation for both-bone diaphyseal forearm fractures in children. Injury. 2014 Aug;45(8):1135-43. doi: 10.1016/j.injury.2014.04.020. Epub 2014 May 2. 95(2):155. doi: 10.1308/rcsann.2013.95.2.155a. 4: Scagliotti GV, Novello S. The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors. Cancer Treat Rev. 2012 Jun;38(4):292-302. doi: 10.1016/j.ctrv.2011.07.008. Epub 2011 Sep 9. 7(1):14-30. doi: 10.2174/157489212798357930.
合成参考文献
参考文献:10.1124/mol.119.115964 摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.